Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

  • Showing results for ryota hirakata. Your search for Ryota Hirahata retrieved no results.
1.

Adipophilin expression is an indicator of poor prognosis in patients with pancreatic ductal adenocarcinoma: An immunohistochemical analysis.

Hashimoto Y, Ishida M, Ryota H, Yamamoto T, Kosaka H, Hirooka S, Yamaki S, Kotsuka M, Matsui Y, Yanagimoto H, Tsuta K, Satoi S.

Pancreatology. 2019 Apr;19(3):443-448. doi: 10.1016/j.pan.2019.03.001. Epub 2019 Mar 11.

PMID:
30879968
2.

Comparative study of programmed cell death ligand-1 immunohistochemistry assays using 22C3 and 28-8 antibodies for non-small cell lung cancer: Analysis of 420 surgical specimens from Japanese patients.

Saito T, Tsuta K, Ishida M, Ryota H, Takeyasu Y, Fukumoto KJ, Matsui H, Taniguchi Y, Yanagimoto H, Kurata T, Murakawa T.

Lung Cancer. 2018 Nov;125:230-237. doi: 10.1016/j.lungcan.2018.10.005. Epub 2018 Oct 6.

PMID:
30429026
3.

Does modified Blumgart anastomosis without intra-pancreatic ductal stenting reduce post-operative pancreatic fistula after pancreaticojejunostomy?

Satoi S, Yamamoto T, Yanagimoto H, Yamaki S, Kosaka H, Hirooka S, Kotsuka M, Ryota H, Michiura T, Inoue K, Matsui Y.

Asian J Surg. 2019 Jan;42(1):343-349. doi: 10.1016/j.asjsur.2018.06.008. Epub 2018 Aug 4.

4.

Clinical impact of developing better practices at the institutional level on surgical outcomes after distal pancreatectomy in 1515 patients: Domestic audit of the Japanese Society of Pancreatic Surgery.

Satoi S, Yamamoto T, Motoi F, Matsumoto I, Yoshitomi H, Amano R, Tahara M, Murakami Y, Arimitsu H, Hirono S, Sho M, Ryota H, Ohtsuka M, Unno M, Takeyama Y, Yamaue H.

Ann Gastroenterol Surg. 2018 Mar 25;2(3):212-219. doi: 10.1002/ags3.12066. eCollection 2018 May.

5.

Comparison Study of PD-L1 Immunohistochemistry Assays with 22C3 and 28-8: Analysis on 147 Surgically Resected NSCLC.

Saito T, Tsuta K, Takeyasu Y, Ryota H, Fukumoto K, Matsui H, Taniguchi Y, Yanagimoto H, Yokoi T, Kurata T, Murakawa T.

Ann Oncol. 2017 Oct;28 Suppl 9:ix84. doi: 10.1093/annonc/mdx697.044. No abstract available.

6.

Clinical effect of pancreaticojejunostomy with a long-internal stent during pancreaticoduodenectomy in patients with a main pancreatic duct of small diameter.

Yamamoto T, Satoi S, Yanagimoto H, Hirooka S, Yamaki S, Ryota H, Kotsuka M, Matsui Y, Kon M.

Int J Surg. 2017 Jun;42:158-163. doi: 10.1016/j.ijsu.2017.04.056. Epub 2017 Apr 29.

7.
8.

Clinical outcomes of pancreatic ductal adenocarcinoma resection following neoadjuvant chemoradiation therapy vs. chemotherapy.

Satoi S, Yanagimoto H, Yamamoto T, Ohe C, Miyasaka C, Uemura Y, Hirooka S, Yamaki S, Ryota H, Michiura T, Inoue K, Matsui Y, Tanigawa N, Kon M.

Surg Today. 2017 Jan;47(1):84-91. Epub 2016 Jun 4.

PMID:
27262676
9.

Safety of laparoscopic cholecystectomy after coronary artery bypass with the right gastroepiploic artery.

Matsui Y, Hirooka S, Ryota H, Yamamoto T, Yanagimoto H, Satoi S, Kon M.

Surgery. 2016 Jul;160(1):252-254. doi: 10.1016/j.surg.2016.02.018. Epub 2016 Apr 1. No abstract available.

PMID:
27046700
10.

Alleviating Effect of Active Hexose Correlated Compound (AHCC) on Chemotherapy-Related Adverse Events in Patients with Unresectable Pancreatic Ductal Adenocarcinoma.

Yanagimoto H, Satoi S, Yamamoto T, Hirooka S, Yamaki S, Kotsuka M, Ryota H, Michiura T, Inoue K, Matsui Y, Tsuta K, Kon M.

Nutr Cancer. 2016;68(2):234-40. doi: 10.1080/01635581.2016.1134597. Epub 2016 Feb 4.

PMID:
26847832
11.

A clinical role of staging laparoscopy in patients with radiographically defined locally advanced pancreatic ductal adenocarcinoma.

Satoi S, Yanagimoto H, Yamamoto T, Toyokawa H, Hirooka S, Yamaki S, Opendro SS, Inoue K, Michiura T, Ryota H, Matsui Y, Kon M.

World J Surg Oncol. 2016 Jan 20;14(1):14. doi: 10.1186/s12957-016-0767-y.

12.

Do pancrelipase delayed-release capsules have a protective role against nonalcoholic fatty liver disease after pancreatoduodenectomy in patients with pancreatic cancer? A randomized controlled trial.

Satoi S, Sho M, Yanagimoto H, Yamamoto T, Akahori T, Kinoshita S, Nagai M, Hirooka S, Yamaki S, Nishiwada S, Ryota H, Ikeda N, Nakajima Y, Kon M.

J Hepatobiliary Pancreat Sci. 2016 Mar;23(3):167-73. doi: 10.1002/jhbp.318. Epub 2016 Feb 14.

PMID:
26748629
13.

Phase I study assessing the feasibility of the triple combination chemotherapy of SOXIRI (S-1/oxaliplatin/irinotecan) in patients with unresectable pancreatic ductal adenocarcinoma.

Yanagimoto H, Satoi S, Sho M, Akahori T, Yamamoto T, Hirooka S, Yamaki S, Kotsuka M, Ryota H, Kinoshita S, Nishiwada S, Nagai M, Ikeda N, Tsuta K, Nakajima Y, Kon M.

Cancer Chemother Pharmacol. 2016 Jan;77(1):35-41. doi: 10.1007/s00280-015-2928-z. Epub 2015 Dec 8.

PMID:
26645403
14.

Low-grade mucinous neoplasia in a cecal diverticulum: A case report.

Nakatani K, Tokuhara K, Sakaguchi T, Ryota H, Yoshioka K, Kon M.

Int J Surg Case Rep. 2015;15:66-9. doi: 10.1016/j.ijscr.2015.08.030. Epub 2015 Aug 20.

15.

Pancreaticogastrostomy following distal pancreatectomy prevents pancreatic fistula-related complications.

Yanagimoto H, Satoi S, Toyokawa H, Yamamoto T, Hirooka S, Yamao J, Yamaki S, Ryota H, Matsui Y, Kwon AH.

J Hepatobiliary Pancreat Sci. 2014 Jul;21(7):473-8. doi: 10.1002/jhbp.59. Epub 2013 Dec 15.

PMID:
24339364
16.

Less morbidity after introduction of a new departmental policy for patients who undergo open distal pancreatectomy.

Yui R, Satoi S, Toyokawa H, Yanagimoto H, Yamamoto T, Hirooka S, Yamaki S, Ryota H, Michiura T, Inoue K, Matsui Y, Kwon AH.

J Hepatobiliary Pancreat Sci. 2014 Jan;21(1):72-7. doi: 10.1002/jhbp.4. Epub 2013 Jun 27.

PMID:
23804436

Supplemental Content

Loading ...
Support Center